2022
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
Which pharma company has completed trials for its intranasal Covid vaccine candidate?
|
|
Biocon
|
|
|
Serum Institute
|
|
|
Bharat Biotech
|
|
|
Dr Reddy’s
|
Explanation:
Detailed explanation-1: -India grants approval for Bharat Biotech’s intranasal Covid-19 vaccine. The vaccine for intranasal delivery via nasal drops was assessed in Phase I, II and III clinical trials with successful data.
Detailed explanation-2: -The iNCOVACC is an adenoviral vector-based SARS CoV-2 vaccine for nasal administration only and its vaccination course consists of two separate doses of 0.5 ml of 8 drops with 4 drops indicated for each nostril.
Detailed explanation-3: -iNCOVACC - Intranasal Vaccine For Covid-19 | Bharat Biotech.
Detailed explanation-4: -It’s a public unlisted company and is classified as’company limited by shares’.
There is 1 question to complete.